{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:43:26Z","timestamp":1789469006432,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry Global Open Science"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bpsgos.2026.100772","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:38:22Z","timestamp":1781912302000},"page":"100772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prazosin-Related Reductions in Daily Craving Mediate Treatment-Related Daily Alcohol Use Outcomes in Alcohol Use Disorder"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-7479","authenticated-orcid":false,"given":"Stephanie","family":"Wemm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3702-1051","authenticated-orcid":false,"given":"Zachary","family":"Harvanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-4349","authenticated-orcid":false,"given":"Rajita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpsgos.2026.100772_bib1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bpsgos.2026.100772_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/0021-843X.106.2.243","article-title":"Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men","volume":"106","author":"Cooney","year":"1997","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109253","article-title":"Alcohol craving and withdrawal at treatment entry prospectively predict alcohol use outcomes during outpatient treatment","volume":"231","author":"Martins","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bpsgos.2026.100772_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamapsychiatry.2022.1240","article-title":"Association of drug cues and craving with drug use and relapse: A systematic review and meta-analysis","volume":"79","author":"Vafaie","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bpsgos.2026.100772_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107569","article-title":"A day-by-day prospective analysis of stress, craving and risk of next day alcohol intake during alcohol use disorder treatment","volume":"204","author":"Wemm","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bpsgos.2026.100772_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cpr.2007.01.002","article-title":"Modeling the complexity of post-treatment drinking: It\u2019s a rocky road to relapse","volume":"27","author":"Witkiewitz","year":"2007","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.bpsgos.2026.100772_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1360-0443.2001.961333.x","article-title":"Theories of drug craving, ancient and modern","volume":"96","author":"Drummond","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.bpsgos.2026.100772_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06298.x","article-title":"The clinical significance of drug craving","volume":"1248","author":"Tiffany","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bpsgos.2026.100772_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2010.09.007","article-title":"Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse","volume":"129","author":"Breese","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bpsgos.2026.100772_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.conb.2013.05.001","article-title":"The clinical neurobiology of drug craving","volume":"23","author":"Sinha","year":"2013","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2014.01.058","article-title":"Differential effects of acute stress on anticipatory and consummatory phases of reward processing","volume":"266","author":"Kumar","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bpsgos.2026.100772_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1037\/xan0000052","article-title":"Stress increases cue-triggered \u201cwanting\u201d for sweet reward in humans","volume":"41","author":"Pool","year":"2015","journal-title":"J Exp Psychol Anim Learn Cogn"},{"key":"10.1016\/j.bpsgos.2026.100772_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11920-011-0224-0","article-title":"New findings on biological factors predicting addiction relapse vulnerability","volume":"13","author":"Sinha","year":"2011","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.bpsgos.2026.100772_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.35946\/arcr.v42.1.12","article-title":"Alcohol\u2019s negative emotional side: The role of stress neurobiology in alcohol use disorder","volume":"42","author":"Sinha","year":"2022","journal-title":"Alcohol Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/B978-0-444-53491-0.00002-X","article-title":"Differential responses of components of the autonomic nervous system","volume":"117","author":"Goldstein","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108997","article-title":"Noradrenergic circuits and signaling in substance use disorders","volume":"208","author":"Downs","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bpsgos.2026.100772_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","article-title":"Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis","volume":"160","author":"O\u2019Malley","year":"2002","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.bpsgos.2026.100772_bib19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/alcalc\/agw038","article-title":"Reductions in alcohol craving following naltrexone treatment for heavy drinking","volume":"51","author":"Helstrom","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fpsyt.2010.00026","article-title":"The effects of naltrexone among alcohol non-abstainers: Results from the COMBINE study","volume":"1","author":"Ray","year":"2010","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2026.100772_bib21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1360-0443.2008.02215.x","article-title":"Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?","volume":"103","author":"Richardson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.bpsgos.2026.100772_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/add.12557","article-title":"Clinical and biological moderators of response to naltrexone in alcohol dependence: A systematic review of the evidence","volume":"109","author":"Garbutt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.bpsgos.2026.100772_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: A randomized clinical trial","volume":"180","author":"Anton","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.bpsgos.2026.100772_bib24","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1530-0277.2009.00986.x","article-title":"A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal","volume":"33","author":"Myrick","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/add.14655","article-title":"A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder","volume":"114","author":"Kranzler","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.bpsgos.2026.100772_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1530-0277.2008.00829.x","article-title":"The \u03b11-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats","volume":"33","author":"Rasmussen","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.alcohol.2007.12.002","article-title":"alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol","volume":"42","author":"Walker","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-011-2178-7","article-title":"Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats","volume":"218","author":"L\u00ea","year":"2011","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.bpsgos.2026.100772_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1530-0277.2011.01628.x","article-title":"Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: Preliminary findings","volume":"36","author":"Fox","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib30","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/acer.14378","article-title":"Effects of prazosin on provoked alcohol craving and autonomic and neuroendocrine response to stress in alcohol use disorder","volume":"44","author":"Milivojevic","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib31","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/add.16484","article-title":"Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trial","volume":"119","author":"Aubin","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.bpsgos.2026.100772_bib32","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1176\/appi.ajp.2018.17080913","article-title":"Double-blind randomized clinical trial of prazosin for alcohol use disorder","volume":"175","author":"Simpson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsgos.2026.100772_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1530-0277.2008.00807.x","article-title":"A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence","volume":"33","author":"Simpson","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/acer.14989","article-title":"A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers: Predictive effects of elevated cardiovascular parameters","volume":"47","author":"Raskind","year":"2023","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"10.1016\/j.bpsgos.2026.100772_bib35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/acer.12703","article-title":"A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder","volume":"39","author":"Simpson","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/appi.ajp.2020.20050609","article-title":"Moderation of prazosin\u2019s Efficacy by alcohol Withdrawal Symptoms","volume":"178","author":"Sinha","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"suppl 2","key":"10.1016\/j.bpsgos.2026.100772_bib37","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1046\/j.1360-0443.95.8s2.9.x","article-title":"Obsessive\u2013compulsive aspects of craving: Development of the Obsessive Compulsive Drinking Scale","volume":"95","author":"Anton","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.bpsgos.2026.100772_bib38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol Withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"},{"key":"10.1016\/j.bpsgos.2026.100772_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1369-1600.2012.00471.x","article-title":"Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment","volume":"18","author":"Kranzler","year":"2013","journal-title":"Addict Biol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1017\/S1461145714000510","article-title":"GRIK1 Genotype moderates topiramate\u2019s effects on daily drinking level, expectations of alcohol\u2019s positive effects and desire to drink","volume":"17","author":"Kranzler","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib41","author":"Revelle"},{"key":"10.1016\/j.bpsgos.2026.100772_bib42","author":"Wickham"},{"key":"10.1016\/j.bpsgos.2026.100772_bib43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/add.14503","article-title":"Compliance with ecological momentary assessment protocols in substance users: A meta-analysis","volume":"114","author":"Jones","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.bpsgos.2026.100772_bib44","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2025.2508","article-title":"Reductions in World Health Organization risk drinking levels as a primary efficacy end point for alcohol clinical trials: A review","volume":"82","author":"Witkiewitz","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bpsgos.2026.100772_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"Witkiewitz","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.bpsgos.2026.100772_bib46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1037\/abn0000771","article-title":"Daily stress predicts later drinking initiation via craving in heavier social drinkers: A prospective in-field daily diary study","volume":"131","author":"Wemm","year":"2022","journal-title":"J Psychopathol Clin Sci"},{"key":"10.1016\/j.bpsgos.2026.100772_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2020.103648","article-title":"The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review","volume":"131","author":"Magill","year":"2020","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.bpsgos.2026.100772_bib48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: A neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bpsgos.2026.100772_bib49","series-title":"Behavioral Neuroscience of Alcohol Addiction","first-page":"379","article-title":"Neural circuitries and alcohol use disorder: Cutting corners in the cycle","author":"Doyle","year":"2023"},{"key":"10.1016\/j.bpsgos.2026.100772_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1176\/appi.ajp.20230849","article-title":"Neural correlates of stress and alcohol cue-induced alcohol craving and of future heavy drinking: Evidence of sex differences","volume":"181","author":"Radoman","year":"2024","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bpsgos.2026.100772_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13116","article-title":"Alcohol withdrawal symptoms predict corticostriatal dysfunction that is reversed by prazosin treatment in alcohol use disorder","volume":"27","author":"Sinha","year":"2022","journal-title":"Addict Biol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116327","article-title":"The use of Experience sampling method in psychopharmacological studies: A systematic review","volume":"344","author":"Quadackers","year":"2025","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bpsgos.2026.100772_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/adb.12192","article-title":"Biobehavioral mechanisms of topiramate\u2019s effects on alcohol use: An investigation pairing laboratory and ecological momentary assessments","volume":"21","author":"Miranda","year":"2016","journal-title":"Addict Biol"},{"key":"10.1016\/j.bpsgos.2026.100772_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addbeh.2018.01.009","article-title":"Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial","volume":"83","author":"Miranda","year":"2018","journal-title":"Addict Behav"},{"key":"10.1016\/j.bpsgos.2026.100772_bib55","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/acer.15411","article-title":"From alcohol and other drug treatment mediator to mechanism to implementation: A systematic review and the cases of self-efficacy, social support, and craving","volume":"48","author":"Maisto","year":"2024","journal-title":"Alcohol Clin Exp Res (Hoboken)"}],"container-title":["Biological Psychiatry Global Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667174326000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667174326000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:22:24Z","timestamp":1789464144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667174326000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2667174326000856"],"URL":"https:\/\/doi.org\/10.1016\/j.bpsgos.2026.100772","relation":{},"ISSN":["2667-1743"],"issn-type":[{"value":"2667-1743","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prazosin-Related Reductions in Daily Craving Mediate Treatment-Related Daily Alcohol Use Outcomes in Alcohol Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry Global Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpsgos.2026.100772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc on behalf of the Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}],"article-number":"100772"}}